Efficacy of Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery in the Treatment of Recurrent Uterine Sarcoma
- 1 June 2018
- journal article
- research article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 28 (6) , 1130-1137
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Uterine SarcomaInternational Journal of Gynecological Cancer, 2016
- Adjuvant therapy for high‐grade, uterus‐limited leiomyosarcomaCancer, 2013
- Surgical cytoreduction in patients with metastatic uterine leiomyosarcoma at the time of initial diagnosisGynecologic Oncology, 2012
- Prognostic factors in uterine sarcomaBest Practice & Research Clinical Obstetrics & Gynaecology, 2011
- Uterine sarcomas: A reviewGynecologic Oncology, 2010
- Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patientsHistopathology, 2009
- Surveillance, Epidemiology, and End Results analysis of 2677 cases of uterine sarcoma 1989–1999Gynecologic Oncology, 2004
- Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy☆Gynecologic Oncology, 2003
- Surgical Resection of Pulmonary and Extrapulmonary Recurrences of Uterine LeiomyosarcomaGynecologic Oncology, 2002
- Prognostic factors in early‐stage uterine sarcoma: A gynecologic oncology group studyCancer, 1993